Literature DB >> 16641466

Erythromycin and clindamycin resistance in group B streptococcal clinical isolates.

Scott E Gygax1, Jessica A Schuyler, Lauren E Kimmel, Jason P Trama, Eli Mordechai, Martin E Adelson.   

Abstract

Erythromycin (EM) and clindamycin (CM) susceptibility testing was performed on 222 clinical isolates of group B Streptococcus. A multiplex PCR assay was used to detect the ermB, ermTR, and mefA/E antibiotic resistance genes. These results were compared to the phenotypes as determined by the standard EM/CM double disk diffusion assay.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16641466      PMCID： PMC1472207          DOI： 10.1128/AAC.50.5.1875-1877.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

Review 1.  Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.

Authors:  M C Roberts; J Sutcliffe; P Courvalin; L B Jensen; J Rood; H Seppala
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing.

Authors:  Marjo Haanperä; Pentti Huovinen; Jari Jalava
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 3.  Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.

Authors:  Roland Leclercq
Journal:  Clin Infect Dis       Date:  2002-01-11       Impact factor: 9.079

4.  A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025.

Authors:  B Bozdogan; L Berrezouga; M S Kuo; D A Yurek; K A Farley; B J Stockman; R Leclercq
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

5.  Detection of erythromycin-resistant determinants by PCR.

Authors:  J Sutcliffe; T Grebe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

6.  Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.

Authors:  D R Murdoch; L B Reller
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 7.  Human intestinal bacteria as reservoirs for antibiotic resistance genes.

Authors:  Abigail A Salyers; Anamika Gupta; Yanping Wang
Journal:  Trends Microbiol       Date:  2004-09       Impact factor: 17.079

8.  Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin.

Authors:  M D Pearlman; C L Pierson; R G Faix
Journal:  Obstet Gynecol       Date:  1998-08       Impact factor: 7.661

9.  Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.

Authors:  D J Farrell; S Douthwaite; I Morrissey; S Bakker; J Poehlsgaard; L Jakobsen; D Felmingham
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

10.  Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.

Authors:  Stephanie Schrag; Rachel Gorwitz; Kristi Fultz-Butts; Anne Schuchat
Journal:  MMWR Recomm Rep       Date:  2002-08-16
View more
  27 in total

1.  Point prevalence study of antibiotic susceptibility of genital group B streptococcus isolated from near-term pregnant women in Calgary, Alberta.

Authors:  Deirdre Church; Julie Carson; Dan Gregson
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

2.  Occurrences and Characterization of Antibiotic-Resistant Bacteria and Genetic Determinants of Hospital Wastewater in a Tropical Country.

Authors:  Thai-Hoang Le; Charmaine Ng; Hongjie Chen; Xin Zhu Yi; Tse Hsien Koh; Timothy Mark Sebastian Barkham; Zhi Zhou; Karina Yew-Hoong Gin
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

3.  High rates of inducible clindamycin resistance among prenatal group B streptococcal isolates in one northwest Louisiana academic medical center.

Authors:  Gerald A Capraro; Ellen D Rambin; John A Vanchiere; Joseph A Bocchini; Janice M Matthews-Greer
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

4.  Characterization of multidrug-resistant group B streptococci with reduced penicillin susceptibility forming small non-Beta-hemolytic colonies on sheep blood agar plates.

Authors:  Hirotsugu Banno; Kouji Kimura; Yosuke Tanaka; Hiromitsu Kitanaka; Wanchun Jin; Jun-ichi Wachino; Keiko Yamada; Keigo Shibayama; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2014-03-12       Impact factor: 5.948

5.  Cross-resistance to lincosamides, streptogramins A and pleuromutilins in Streptococcus agalactiae isolates from the USA.

Authors:  Paulina A Hawkins; Caitlin S Law; Benjamin J Metcalf; Sopio Chochua; Delois M Jackson; Lars F Westblade; Robert Jerris; Bernard W Beall; Lesley McGee
Journal:  J Antimicrob Chemother       Date:  2017-07-01       Impact factor: 5.790

6.  Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy.

Authors:  M A De Francesco; S Caracciolo; F Gargiulo; N Manca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-26       Impact factor: 3.267

7.  Pharmacokinetics of clindamycin in pregnant women in the peripartum period.

Authors:  Anouk E Muller; Johan W Mouton; Paul M Oostvogel; P Joep Dörr; Rob A Voskuyl; Joost DeJongh; Eric A P Steegers; Meindert Danhof
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

8.  Identification of a novel keyhole phenotype in double-disk diffusion assays of clindamycin-resistant erythromycin-sensitive strains of Streptococcus agalactiae.

Authors:  Usha Srinivasan; Brady Miller; Joan Debusscher; Carl F Marrs; Lixin Zhang; Yong Soo Seo; Kwan-Young Oh; Moon Young Kim; Hye-Ryung Yoon; Moran Kl; Betsy Foxman
Journal:  Microb Drug Resist       Date:  2010-12-18       Impact factor: 3.431

9.  Changing molecular epidemiology of group B streptococcus in Korea.

Authors:  Yong Soo Seo; Usha Srinivasan; Kwan-Young Oh; Jung-Hwan Shin; Jeong Don Chae; Moon Young Kim; Jae Hyug Yang; Hye-Ryung Yoon; Brady Miller; Joan DeBusscher; Betsy Foxman; Moran Ki
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

10.  Emergence of respiratory Streptococcus agalactiae isolates in cystic fibrosis patients.

Authors:  Vera Eickel; Barbara Kahl; Beatrice Reinisch; Angelika Dübbers; Peter Küster; Claudia Brandt; Barbara Spellerberg
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.